NEW YORK, July 27 (Praxis Press) Lung-volume-reduction surgery is thought to improve lung function, walking distance, and quality of life in patients with severe emphysema, but the benefits of this ...
Surgery in which doctors remove diseased portions of the lungs clearly helps some people with emphysema, a new study finds. But the likelihood of benefit depends on the location of the damaged tissues ...
As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for advanced emphysema may survive longer and with fewer complications than they did ...
The first randomized controlled trial to compare two lung volume reduction procedures for people with emphysema has found that both lead to similar improvements in lung function, breathlessness and ...
The National Emphysema Treatment Trial (NETT) was a multicenter, randomized, controlled clinical trial comparing the efficacy of lung volume reduction surgery (LVRS) plus medical management with ...
St. Louis, March 25, 2003 -- A procedure known as lung-volume reduction surgery (LVRS) appears to improve overall health and quality of life for individuals with end-stage emphysema, and these effects ...
Results from a study on bronchoscopic lung volume reduction and lung volume reduction surgery may aid medical professionals in selecting the best treatment for patients with emphysema. A recent study ...
Use of lung volume reduction surgery (LVRS) increased in the mid-1990s as a palliative therapy for severe emphysema. Rapid growth in procedure volume despite little evidence supporting its safety and ...
Patients with chronic obstructive pulmonary disease (COPD) are more likely to die within a year of undergoing elective surgery and to incur higher healthcare costs than similar patients without COPD, ...
TEXARKANA, Texas -- A relatively new surgery is giving COPD and emphysema sufferers hope for better quality of life. Zephyr Endobronchial Valve treatment blocks areas of the lung that have been ...
Major surgery is a challenge for people with chronic obstructive pulmonary disease (COPD), raising their odds of death within a year by 61%, new research shows. The researchers also found these ...
Centers for Medicare and Medicaid Services, formerly HCFA, decided to stop covering the procedure, which costs between $25,000 and $60,000, a move that subjected the agency to "intense criticism." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results